How Long Does It Take to Feel Wegovy Side Effects?

What the STEP 1 trial data show about when side effects appear

The clearest picture of Wegovy's side-effect timeline comes from the STEP 1 trial, published in the New England Journal of Medicine, which followed adults on semaglutide 2.4mg for 68 weeks. Gastrointestinal effects, chiefly nausea, were the most common finding. They clustered around two predictable moments: the start of treatment and each dose increase. If you are wondering how long after taking Wegovy you feel side effects, the trial data suggest that within the first one to four days of a new or increased dose, most participants who experienced GI symptoms noticed them. For the majority, those symptoms peaked in the first week and reduced substantially over the following one to two weeks as the body adjusted. This is not a quirk of the trial population — the pattern is consistent with how GLP-1 receptor agonists slow gastric emptying and alter appetite signalling.

The side-effect profile documented in STEP 1 included nausea, vomiting, diarrhoea, constipation, indigestion and burping. Fatigue, headache and dizziness were also reported, though less frequently. Injection-site reactions are possible too. The NHS medicines page for semaglutide describes these as generally self-limiting, meaning they tend to resolve without intervention as you move through the gradual dose escalation that runs from 0.25mg up to the 2.4mg maintenance dose.

One practical anchor: many people find it helpful to keep their pen in the fridge door alongside other everyday items, a small, visible routine that also makes it easier to notice if you store the pen correctly and remember your weekly injection day.

Why symptoms are often more noticeable at each dose step

The semaglutide titration schedule is deliberately slow (around four weeks at each dose level) largely because GI side effects are more likely when the dose rises quickly. Even so, some people experience a return of mild nausea at each step up, even if they had settled between steps. This is not a sign that the medicine is not working or that something has gone wrong; it reflects the pharmacology. The body is readjusting to a new concentration of the drug.

Practically, this means side effects are rarely a single episode in week one. They can resurface, briefly, at weeks five, nine and thirteen as the dose increases. For most people each recurrence is milder than the one before. Eating smaller portions, choosing lower-fat foods during adjustment periods and staying well hydrated are commonly recommended strategies, though any specific advice for your situation should come from your prescriber or the Patient Information Leaflet, not a general article.

People often ask how long nausea on Wegovy lasts, the honest answer is that it varies, but a window of one to two weeks per dose step covers the experience of most trial participants. For a broader look at how long it takes to feel side effects of Wegovy, including what influences that timing for different people, that question is covered in more detail separately. A minority do not experience significant GI effects at all. A smaller minority find them persistent; that is exactly the conversation to have with a prescriber, not something to manage alone.

Side effects that need prompt medical attention

Most Wegovy side effects are a temporary adjustment, not a danger signal. But some symptoms warrant contacting a doctor or, in an emergency, calling 999 without delay. Knowing these before you start is part of what a thorough clinical review covers.

In January 2026 the MHRA issued a Drug Safety Update highlighting acute pancreatitis as a known but infrequent side effect of GLP-1 medicines that can be serious. The warning sign is severe, persistent stomach pain that may reach through to the back, sometimes accompanied by vomiting. This is distinct from ordinary nausea; it does not settle by itself in a few hours. Seek urgent medical help if you experience it.

Other symptoms that should not be left unaddressed include signs of gallbladder problems (pain in the upper right abdomen, especially after eating), symptoms suggesting dehydration or kidney strain following severe vomiting or diarrhoea, any allergic reaction (swelling of the face or throat, difficulty breathing), or a sudden change in vision. Low mood or thoughts of self-harm are also listed in prescribing information as requiring prompt medical contact. The MHRA's Yellow Card scheme exists so that patients can report suspected side effects directly, which helps the regulator monitor medicines in real-world use. It is open to anyone, not just clinicians.

For a fuller picture of Wegovy's overall safety record, the Wegovy safety profile page covers the evidence in more depth.

How long it is reasonable to persist with side effects, and when to ask for help

There is no universal threshold after which side effects become unacceptable, that is a clinical judgement. What matters is that you are not left managing them alone. If symptoms are severe enough to disrupt daily life, or if they are not improving after two to three weeks at a stable dose, that is a conversation for your prescriber, not a reason to simply stop without advice. Stopping abruptly is itself something to discuss with a clinician; the question of how long it is safe to take Wegovy involves more than just the side-effect picture.

At nume, the same prescriber who reviews your consultation is available to field exactly these questions through our priority aftercare service, seven days a week. If you are weighing up whether Wegovy is likely to suit you, or are already on treatment and finding the adjustment harder than expected, a conversation with a qualified clinician is always the right next step. You can read more about Wegovy as a treatment, or start a free consultation to speak with our prescribers directly.